2 months ago
AXSM
AnalystsSean LaamanSean Laaman's Stock Forecasts
AnalystsSean Laaman
Analyst Ranking
Top 24%
#1233 out of 5177 analysts
Average Return
+19.93%
Win Rate
80%16 out of 20
Risk vs Reward
Poor
Good
Sean Laaman's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Resmed IncRMD | +90.17% | $134.65 | $256.07 | 2023-10-26 - 2024-10-25 | Strong Buy |
Beone Medicines LtdONC | +60.28% | $206.01 | $330.19 | 2024-12-02 - 2025-12-02 | Strong Buy |
Axsome Therapeutics IncAXSM | +58.91% | $105.44 | $167.55 | 2025-07-02 - 2026-01-08 | Strong Buy |
Beone Medicines LtdONC | +40.21% | $241.20 | $338.19 | 2025-06-26 - 2026-01-16 | Strong Buy |
Disc Medicine IncIRON | +29.55% | $54.75 | $70.93 | 2025-07-02 - 2026-01-16 | Strong Buy |
Sean Laaman Analyst Color
Get additional color on Sean Laaman's coverage of popular stocks
3 months ago
ONC
Sean Laaman's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Axsome Therapeutics IncAXSM | 4 | Hold | $204.00 | +15.08% | Downgrades | 9 days ago |
Exelixis IncEXEL | 5 | Hold | $48.00 | +9.19% | Downgrades | 9 days ago |
Bridgebio Pharma IncBBIO | 1 | Strong Buy | $96.00 | +25.89% | Initiates Coverage On | 11 days ago |
Certara IncCERT | 2 | Hold | $12.00 | +26.18% | Maintains | a month ago |
Bridgebio Oncology Therapeutics IncBBOT | 1 | Strong Buy | $20.00 | +75.21% | Initiates Coverage On | a month ago |
Maplight Therapeutics IncMPLT | 1 | Strong Buy | $34.00 | +100.00% | Initiates Coverage On | 2 months ago |
Disc Medicine IncIRON | 3 | Strong Buy | $115.00 | +62.13% | Maintains | 3 months ago |
Resmed IncRMD | 2 | Strong Buy | $304.00 | +18.02% | Maintains | 3 months ago |
Beone Medicines LtdONC | 3 | Strong Buy | $383.00 | +13.25% | Maintains | 3 months ago |
Alector IncALEC | 1 | Strong Sell | $1.50 | -18.48% | Assumes | 10 months ago |
Halozyme Therapeutics IncHALO | 1 | Strong Buy | $67.00 | -5.91% | Assumes | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.